Attached files

file filename
8-K - FORM 8-K - MAXLINEAR INCd479726d8k.htm

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

MaxLinear, Inc. Announces

Fourth Quarter and Fiscal Year 2012 Financial Results

$24.8 Million Fourth Quarter Revenue Grows 29 percent Year-over-Year

Carlsbad, Calif. – February 5th, 2013 – MaxLinear, Inc. (NYSE: MXL), a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications applications, today announced financial results for the fourth quarter and fiscal year ended December 31, 2012.

Management Commentary

“We are pleased to announce that in the fourth quarter, we realized revenue of $24.8 million, which represents growth of 29 percent year-over-year, and brings to close a successful year, one in which we delivered annual revenue growth of 36 percent and positive cash flow from operations,” commented Kishore Seendripu, Ph.D., Chairman and CEO. “Our revenue growth in 2012 reflected strong momentum in Cable combined with stabilization of our terrestrial revenues as we brought to market new offerings across a range of television and hybrid set-top applications. Not only were we able to deliver this strong revenue growth in 2012, but we continue to execute admirably on new and exciting product development initiatives that will further expand our addressable market opportunity.”

Generally Accepted Accounting Principles (GAAP) Results

Net revenue for the fourth quarter of 2012 was $24.8 million, a decrease of 11 percent compared to the third quarter of 2012 and an increase of 29 percent compared to the fourth quarter of 2011. Gross profit in the fourth quarter of 2012 was 63 percent of revenue, compared to 63 percent in the third quarter of 2012 and 61 percent in the fourth quarter of 2011.

Net loss for the fourth quarter of 2012 was $4.6 million, or $0.14 per share (diluted), compared with net income of $0.5 million, or $0.01 per share (diluted), for the third quarter of 2012 and net loss of $4.7 million, or $0.14 per share (diluted), for the fourth quarter of 2011. The primary drivers of the $5.0 million change in profitability relative to the third quarter of 2012 include; $3 million less revenue which was influenced by customers desire to reduce their year-end inventories, approximately $1.3 million in incremental expenses related to a 40 nanometer R&D tape-out, and approximately $0.7 million increase in net professional fees related to our ongoing IP litigation with Silicon Laboratories, and the impact of net headcount additions in the quarter.


Positive cash flow provided by operations for the fourth quarter of 2012 totaled $1.4 million, compared with $6.3 million for the third quarter of 2012, and negative cash flow used in operations of $1.9 million in the fourth quarter of 2011.

Cash, cash equivalents and investments totaled $77.3 million at December 31, 2012, compared to $80.0 million at September 30, 2012, and $85.7 million at December 31, 2011. These decreases were primarily attributable to stock repurchases from our remaining venture capital investor, which was partially offset by operating cash flow generation.

For the fiscal year 2012, net revenue was $97.7 million, representing an increase of 36 percent compared to $71.9 million in fiscal 2011. Gross profit was 62 percent of revenue for fiscal 2012, compared to 63 percent for fiscal 2011. Net loss for fiscal 2012 was $13.3 million, or $0.40 per share (diluted), compared with net loss of $22.0 million, or $0.68 per share (diluted), in fiscal 2011. Positive cash flow provided by operations for fiscal 2012 totaled $7.5 million, compared with negative cash flow used in operations of $7.1 million in fiscal 2011.

Non-GAAP Results

Non-GAAP gross profit in the fourth quarter of 2012 was 63 percent of revenue, compared to 63 percent in the third quarter of 2012 and 61 percent in the fourth quarter of 2011.

Non-GAAP net income for the fourth quarter of 2012 was $0.7 million, or $0.02 per share (diluted), compared with $4.3 million, or $0.13 per share (diluted), for the third quarter of 2012, and non-GAAP net loss of $1.5 million, or $0.05 per share (diluted), for the fourth quarter of 2011.

For the fiscal year 2012, non-GAAP gross profit was 62 percent of revenue, compared to 63 percent for fiscal 2011. Non-GAAP net income for fiscal 2012 was $4.8 million, or $0.14 per share (diluted), compared with non-GAAP net loss of $3.7 million, or $0.11 per share (diluted), in fiscal 2011.

First Quarter 2013 Revenue Guidance

We expect revenue in the first quarter of 2013 to increase approximately 5% to 10% sequentially to $26 to $27 million.

Conference Call Details

MaxLinear will host its fourth quarter 2012 financial results conference call today, February 5, 2013 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-941-2068 / International: 1-480-629-9712 with conference ID: 4588060. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at www.maxlinear.com, and will be archived and available after the call at http://investors.maxlinear.com until February 19, 2013. A replay of the conference call will also be available until February 19, 2013 by dialing US toll free: 1-800-406-7325 / International: 1-303-590-3030 and referencing passcode: 4588060.


Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance, trends and growth opportunities in specific product markets such as cable and terrestrial applications, and opportunities associated with new product offerings and our strategy to expand our addressable market. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. Risks and uncertainties affecting our business and operating results, include, among others, intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; uncertainties concerning how end user markets for our products will develop, including end user markets for the cable and terrestrial applications of our products as well as end user markets for products currently in development; our ability to develop and introduce new and enhanced products on a timely basis and achieve market acceptance of those products, particularly as we seek to expand outside of our historic markets; potential decreases in average selling prices for our products; the timing and development of the global transition from analog to digital television; intellectual property risks, including risks arising from our continuing intellectual property litigation with Silicon Laboratories; our reliance on a limited number of third party manufacturers; and our lack of long-term supply contracts and dependence on limited sources of supply. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our most recent Annual Report on Form 10-K, which MaxLinear expects to file with the SEC in February 2013.

Use of Non-GAAP Financial Measures

To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP net income (loss), income (loss) from operations, gross profit, and earnings (loss) per share. These supplemental measures exclude the effects of (i) stock-based compensation expense and its related tax effect, if any; (ii) an accrual related to our performance based bonus plan for 2012, which will be settled in stock in 2013; (iii) expenses associated with our acquisition of certain new market related technology licenses; (iv) estimated fines and penalties and professional fees related to our previously disclosed export compliance and IP litigation matters; and (v) the valuation allowance on federal deferred tax assets. These non-GAAP measures are not in accordance with and do not serve as an alternative for GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. These non-GAAP measures should only be viewed in conjunction with corresponding GAAP measures. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.

We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.


The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:

Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. In addition, we exclude the related tax effect of stock-based compensation expense, if any, from non-GAAP net income.

Any bonus payments excluded from our non-GAAP net income under our 2012 bonus plans will be settled through the issuance of shares of Class A common stock under our equity incentive plans. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.

Expenses incurred in relation to the purchase of certain new market related technology licenses, intellectual property litigation and estimated fines and penalties and professional fees related to export compliance matters are unrelated to our underlying business. Therefore, we do not believe these are indicative of our core operating performance and exclude these expenses in management evaluations of our business.

Expenses incurred in relation to our export compliance review include (i) charges relating to estimates of potential export compliance fines and penalties, and (ii) professional fees incurred as a result of our audit committee’s review and the final voluntary disclosures submitted to governmental agencies.

Expenses incurred in relation to our intellectual property litigation with Silicon Laboratories include professional fees incurred. MaxLinear believes the lawsuit is without merit and intends to vigorously defend itself.

The provision for income taxes for the twelve months ended December 31, 2011 includes a valuation allowance related to federal deferred tax assets. We do not believe the recording of the valuation allowance is indicative of our core operating performance.

Reconciliations of non-GAAP measures disclosed in this press release appear below.

About MaxLinear, Inc.

MaxLinear, Inc. is a provider of integrated, radio-frequency (RF) and mixed-signal integrated circuits for broadband communications applications. MaxLinear is located in Carlsbad, California, and its address on the Internet is www.maxlinear.com.

MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.


MaxLinear, Inc. Investor Relations Contacts:

Nick Kormeluk

IR Sense

Tel: 949-415-7745

nick@irsense.com

MaxLinear, Inc. Corporate Contact:

Adam Spice

Chief Financial Officer

Tel: 760-692-0711, Extension 196


MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

     Three Months Ended  
     December 31,     September 30,     December 31,  
     2012     2012     2011  

Net revenue

   $ 24,830      $ 27,795      $ 19,296   

Cost of net revenue

     9,126        10,328        7,573   
  

 

 

   

 

 

   

 

 

 

Gross profit

     15,704        17,467        11,723   

Operating expenses:

      

Research and development

     12,634        10,855        10,179   

Selling, general and administrative

     7,475        6,167        5,849   
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     20,109        17,022        16,028   
  

 

 

   

 

 

   

 

 

 

Income (loss) from operations

     (4,405     445        (4,305

Interest income

     61        74        58   

Interest expense

     (8     (11     (31

Other expense, net

     (123     (14     (131
  

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     (4,475     494        (4,409

Provision for income taxes

     106        44        283   
  

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (4,581   $ 450      $ (4,692
  

 

 

   

 

 

   

 

 

 

Net income (loss) per share:

      

Basic

   $ (0.14   $ 0.01      $ (0.14
  

 

 

   

 

 

   

 

 

 

Diluted

   $ (0.14   $ 0.01      $ (0.14
  

 

 

   

 

 

   

 

 

 

Shares used to compute net income (loss) per share:

      

Basic

     32,591        33,316        33,056   
  

 

 

   

 

 

   

 

 

 

Diluted

     32,591        34,547        33,056   
  

 

 

   

 

 

   

 

 

 


MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

     Twelve Months Ended
December 31,
 
     2012     2011  

Net revenue

   $ 97,728      $ 71,937   

Cost of net revenue

     37,019        26,616   
  

 

 

   

 

 

 

Gross profit

     60,709        45,321   

Operating expenses:

    

Research and development

     46,392        40,156   

Selling, general and administrative

     27,225        20,178   
  

 

 

   

 

 

 

Total operating expenses

     73,617        60,334   
  

 

 

   

 

 

 

Loss from operations

     (12,908     (15,013

Interest income

     282        292   

Interest expense

     (53     (69

Other expense, net

     (232     (241
  

 

 

   

 

 

 

Loss before income taxes

     (12,911     (15,031

Provision for income taxes

     341        6,993   
  

 

 

   

 

 

 

Net loss

   $ (13,252   $ (22,024
  

 

 

   

 

 

 

Net loss per share:

    

Basic

   $ (0.40   $ (0.68
  

 

 

   

 

 

 

Diluted

   $ (0.40   $ (0.68
  

 

 

   

 

 

 

Shares used to compute net loss per share:

    

Basic

     33,198        32,573   
  

 

 

   

 

 

 

Diluted

     33,198        32,573   
  

 

 

   

 

 

 


MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

     Three Months Ended  
     December 31,
2012
    September 30,
2012
    December 31,
2011
 

Operating Activities

      

Net income (loss)

   $ (4,581   $ 450      $ (4,692

Adjustments to reconcile net income (loss) to cash used in operating activities:

      

Amortization and depreciation

     970        860        865   

Amortization of investment premiums, net

     251        257        285   

Stock-based compensation

     2,820        2,609        2,162   

Gain on sale of available-for-sale securities

     (2     —          —     

Write down of long-lived assets

     113        —          121   

Changes in operating assets and liabilities:

      

Accounts receivable

     1,721        (1,331     (2,036

Inventory

     (945     (409     1,146   

Prepaid and other assets

     (99     207        (28

Accounts payable and accrued expenses

     107        565        (843

Accrued compensation

     1,018        1,727        (674

Deferred revenue and deferred profit

     (52     116        1,532   

Accrued price protection liability

     (72     1,249        348   

Other long-term liabilities

     113        7        (123
  

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     1,362        6,307        (1,937

Investing Activities

      

Purchases of property and equipment

     (2,029     (1,400     (775

Purchases of intangible assets

     —          (195     (201

Purchases of available-for-sale securities

     (21,528     (8,909     (40,402

Maturities of available-for-sale securities

     19,251        27,049        26,775   
  

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (4,306     16,545        (14,603

Financing Activities

      

Payments on capital leases

     (2     (1     (24

Net proceeds from issuance of common stock

     961        507        1,060   

Repurchases of common stock

     (2,840     (9,236     —     
  

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (1,881     (8,730     1,036   
  

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     1        —          9   

Increase (decrease) in cash and cash equivalents

     (4,824     14,122        (15,495

Cash and cash equivalents at beginning of period

     26,634        12,512        43,521   
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 21,810      $ 26,634      $ 28,026   
  

 

 

   

 

 

   

 

 

 


MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

     Twelve Months Ended
December 31,
 
   2012     2011  

Operating Activities

    

Net loss

   $ (13,252   $ (22,024

Adjustments to reconcile net loss to cash used in operating activities:

    

Amortization and depreciation

     3,531        3,159   

Amortization of investment premiums, net

     1,058        1,179   

Stock-based compensation

     9,984        7,368   

Deferred income taxes

     —          6,668   

Gain on the sale of available-for-sale securities

     (2     (9

Write down of long-lived assets

     184        150   

Changes in operating assets and liabilities:

    

Accounts receivable

     (4,137     (7,374

Inventory

     (1,809     (657

Prepaid and other assets

     (129     155   

Accounts payable and accrued expenses

     3,981        4,368   

Amounts due to related party

     —          (1,746

Accrued compensation

     4,910        (51

Deferred revenue and deferred profit

     (1,740     (1,293

Accrued price protection liability

     5,024        2,400   

Other long-term liabilities

     (59     598   
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     7,544        (7,109

Investing Activities

    

Purchases of property and equipment

     (5,055     (2,962

Purchases of intangible assets

     (390     (201

Purchases of available-for-sale securities

     (87,897     (111,369

Maturities of available-for-sale securities

     89,151        125,350   
  

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (4,191     10,818   

Financing Activities

    

Payments on capital leases

     (32     (82

Net proceeds from issuance of common stock

     2,531        2,815   

Repurchases of common stock

     (12,076     —     
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (9,577     2,733   
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     8        21   

Increase (decrease) in cash and cash equivalents

     (6,216     6,463   

Cash and cash equivalents at beginning of period

     28,026        21,563   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 21,810      $ 28,026   
  

 

 

   

 

 

 


MAXLINEAR, INC.

UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

     December 31,      September 30,      December 31,  
     2012      2012      2011  

Assets

        

Current assets:

        

Cash and cash equivalents

   $ 21,810       $ 26,634       $ 28,026   

Short-term investments, available-for-sale

     50,265         50,792         47,156   

Accounts receivable, net

     14,558         16,279         10,421   

Inventory

     9,891         8,946         8,082   

Prepaid expenses and other current assets

     1,494         1,394         1,394   
  

 

 

    

 

 

    

 

 

 

Total current assets

     98,018         104,045         95,079   

Property and equipment, net

     6,866         6,274         5,494   

Long-term investments, available-for-sale

     5,181         2,619         10,554   

Intangible assets

     275         461         1,021   

Other long-term assets

     257         258         228   
  

 

 

    

 

 

    

 

 

 

Total assets

   $ 110,597       $ 113,657       $ 112,376   
  

 

 

    

 

 

    

 

 

 

Liabilities and stockholders’ equity

        

Current liabilities

   $ 29,568       $ 29,093       $ 18,494   

Other long-term liabilities

     796         683         855   

Capital lease obligations, net of current portion

     —           —           2   

Total stockholders’ equity

     80,233         83,881         93,025   
  

 

 

    

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 110,597       $ 113,657       $ 112,376   
  

 

 

    

 

 

    

 

 

 


MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

     Three Months Ended  
     December 31,
2012
    September 30,
2012
     December 31,
2011
 

GAAP net income (loss)

   $ (4,581   $ 450       $ (4,692

Stock-based compensation:

       

Cost of net revenue

     24        23         16   

Research and development

     1,792        1,661         1,420   

Selling, general and administrative

     1,003        925         726   
  

 

 

   

 

 

    

 

 

 

Total stock-based compensation

     2,819        2,609         2,162   

Share-based bonus plan*:

       

Cost of net revenue

     12        12         —     

Research and development

     750        699         —     

Selling, general and administrative

     583        490         —     
  

 

 

   

 

 

    

 

 

 

Total share-based bonus plan

     1,345        1,201         —     

Acquisition of technology licenses

     —          —           275   

Estimated export compliance and IP litigation costs, net **

     1,088        75         750   
  

 

 

   

 

 

    

 

 

 

Non-GAAP net income (loss)

   $ 671      $ 4,335       $ (1,505
  

 

 

   

 

 

    

 

 

 

Shares used in computing non-GAAP basic net income (loss) per share

     32,591        33,316         33,056   
  

 

 

   

 

 

    

 

 

 

Shares used in computing GAAP diluted net income (loss) per share

     32,591        33,316         33,056   

Dilutive common stock equivalents

     1,157        1,231         —     
  

 

 

   

 

 

    

 

 

 

Shares used in computing non-GAAP diluted net income (loss) per share

     33,748        34,547         33,056   
  

 

 

   

 

 

    

 

 

 

Non-GAAP basic net income (loss) per share

   $ 0.02      $ 0.13       $ (0.05
  

 

 

   

 

 

    

 

 

 

Non-GAAP diluted net income (loss) per share

   $ 0.02      $ 0.13       $ (0.05
  

 

 

   

 

 

    

 

 

 

 

* Share-based bonus plan for the three months ended December 31, 2012 and September 30, 2012 relates to an accrual related to our performance based bonus plan for 2012, which will be settled in stock in 2013.
** Estimated export compliance and IP litigation costs, net for the three months ended December 31, 2012 and September 30, 2012 includes the reduction of previously recorded export compliance fines and penalties of $250 and $625, respectively.


MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

     Twelve Months Ended
December 31,
 
     2012     2011  

GAAP net loss

   $ (13,252   $ (22,024

Stock-based compensation:

    

Cost of net revenue

     85        54   

Research and development

     6,382        4,434   

Selling, general and administrative

     3,517        2,880   
  

 

 

   

 

 

 

Total stock-based compensation

     9,984        7,368   

Share-based bonus plan*:

    

Cost of net revenue

     45        —     

Research and development

     3,021        —     

Selling, general and administrative

     1,956        —     
  

 

 

   

 

 

 

Total share-based bonus plan

     5,022        —     

Acquisition of technology licenses

     285        3,573   

Estimated export compliance and IP litigation costs**

     2,776        750   

Income taxes***

     —          6,668   
  

 

 

   

 

 

 

Non-GAAP net income (loss)

   $ 4,815      $ (3,665
  

 

 

   

 

 

 

Shares used in computing non-GAAP basic net income (loss) per share

     33,198        32,573   
  

 

 

   

 

 

 

Shares used in computing GAAP diluted net income (loss) per share

     33,198        32,573   

Dilutive common stock equivalents

     1,080        —     
  

 

 

   

 

 

 

Shares used in computing non-GAAP diluted net income (loss) per share

     34,278        32,573   
  

 

 

   

 

 

 

Non-GAAP basic net income (loss) per share

   $ 0.15      $ (0.11
  

 

 

   

 

 

 

Non-GAAP diluted net income (loss) per share

   $ 0.14      $ (0.11
  

 

 

   

 

 

 

 

* Share-based bonus plan for the twelve months ended December 31, 2012 relates to an accrual related to our performance based bonus plan for 2012, which will be settled in stock in 2013.
** Estimated export compliance and IP litigation costs, net for the twelve months ended December 31, 2012 includes the reduction of previously recorded export compliance fines and penalties of $875.
*** Income taxes for the twelve months ended December 31, 2011 illustrate the financial results without the effects of the recording of the valuation allowance related to federal deferred tax assets.


MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

 

     Three Months Ended  
     December 31,     September 30,     December 31,  
     2012     2012     2011  

GAAP gross profit as a % of revenue

     63.2     62.8     60.8

Stock-based compensation:

      

Cost of net revenue

     0.1     0.1     0.1

Share-based bonus plan:

      

Cost of net revenue

     0.1     0.1     —     
  

 

 

   

 

 

   

 

 

 

Non-GAAP gross profit as a % of revenue

     63.4     63.0     60.9
  

 

 

   

 

 

   

 

 

 

GAAP income (loss) from operations as a % of revenue

     (17.7 )%      1.6     (22.3 )% 

Stock-based compensation:

      

Cost of net revenue

     0.1     0.1     0.1

Research and development

     7.2     6.0     7.4

Selling, general and administrative

     4.0     3.3     3.8

Share-based bonus plan:

      

Cost of net revenue

     0.1     0.1     —     

Research and development

     3.0     2.5     —     

Selling, general and administrative

     2.3     1.7     —     

Acquisition of technology licenses

     —          —          1.4

Estimated export compliance and IP litigation costs

     4.4     0.3     3.9
  

 

 

   

 

 

   

 

 

 

Non-GAAP income (loss) from operations as a % of revenue

     3.4     15.6     (5.7 )% 
  

 

 

   

 

 

   

 

 

 


MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

 

     Twelve Months  Ended
December 31,
 
     2012     2011  

GAAP gross profit as a % of revenue

     62.1     63.0

Stock-based compensation:

    

Cost of net revenue

     0.1     0.1

Share-based bonus plan:

    

Cost of net revenue

     0.1     —     
  

 

 

   

 

 

 

Non-GAAP gross profit as a % of revenue

     62.3     63.1
  

 

 

   

 

 

 

GAAP loss from operations as a % of revenue

     (13.2 )%      (20.9 )% 

Stock-based compensation:

    

Cost of net revenue

     0.1     0.1

Research and development

     6.5     6.2

Selling, general and administrative

     3.6     4.0

Share-based bonus plan:

    

Cost of net revenue

     0.1     —     

Research and development

     3.1     —     

Selling, general and administrative

     2.0     —     

Acquisition of technology licenses

     0.3     5.0

Estimated export compliance and IP litigation costs

     2.8     1.0
  

 

 

   

 

 

 

Non-GAAP income (loss) from operations as a % of revenue

     5.3     (4.6 )%